Ruotsi - ruotsi - Läkemedelsverket (Medical Products Agency)

accord healthcare b.v. - kolekalciferol; natriumalendronattrihydrat - tablett - 70 mg/5600 ie - natriumalendronattrihydrat 91,36 mg aktiv substans; kolekalciferol 5600 ie aktiv substans; sackaros hjälpämne; butylhydroxitoluen hjälpämne; laktos (vattenfri) hjälpämne

Ruotsi - ruotsi - Läkemedelsverket (Medical Products Agency)

ebb medical ab - kolekalciferol; natriumalendronattrihydrat - tablett - 70 mg/2800 ie - kolekalciferol 70 mikrog aktiv substans; natriumalendronattrihydrat 91,36 mg aktiv substans; laktos (vattenfri) hjälpämne; butylhydroxitoluen hjälpämne; sackaros hjälpämne

Ruotsi - ruotsi - Läkemedelsverket (Medical Products Agency)

strides pharma (cyprus) limited - omega-3-syraetylestrar 90 - kapsel, mjuk - 1000 mg - natriumlaurilsulfat hjälpämne; glycerol hjälpämne; omega-3-syraetylestrar 90 1000 mg aktiv substans; propylenglykol hjälpämne

Ruotsi - ruotsi - Läkemedelsverket (Medical Products Agency)

ebb medical ab - omega-3-syraetylestrar 90 - kapsel, mjuk - 1000 mg - omega-3-syraetylestrar 90 1000 mg aktiv substans; glycerol hjälpämne; sojalecitin hjälpämne

Euroopan unioni - ruotsi - EMA (European Medicines Agency)

amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemi - lipidmodifierande medel - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Euroopan unioni - ruotsi - EMA (European Medicines Agency)

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immunförsvaret sera och immunglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Euroopan unioni - ruotsi - EMA (European Medicines Agency)

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. användning av detta vaccin bör ske i enlighet med officiella rekommendationer. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. användning av detta vaccin bör ske i enlighet med officiella rekommendationer.

Euroopan unioni - ruotsi - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Euroopan unioni - ruotsi - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.